Product Information
MOXIFLOXACIN 0.5% EYE DROPS is a generic product labeled by Aurobindo Pharma Limited, priced at $1.5963 per ML under NDC 65862084003. Its NADAC has been published 430 times since Jul 11, 2018.
FDA first approved this application on Oct 4, 2017. Its Orange Book therapeutic-equivalence code is AT1.
Strength
5 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862084003
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206242FDA Approved
10/4/2017
TE Code
AT1
On Market Since
10/4/2017
Pharmacological Classes
Price Statistics
The NADAC for MOXIFLOXACIN 0.5% EYE DROPS has been published 430 times since Jul 11, 2018, and over the history we have for it it has declined 80.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5963 per ML |
|---|---|
| All-time high | $8.3576 (Jul 11, 2018) |
| All-time low | $1.5386 (Aug 19, 2026) |
| 52-week high | $1.8460 |
| 52-week low | $1.5386 |
| Median price | $3.6153 |
| Average price | $4.3009 |
| Largest weekly change | +41.1% (Nov 23, 2022) |
| Weeks tracked | 430 |
| Tracking since | Jul 11, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MOXIFLOXACIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOXIFLOXACIN 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for MOXIFLOXACIN 0.5% EYE DROPS, manufactured by Aurobindo Pharma Limited, is $1.5963 per ML (NDC 65862084003), effective Sep 30, 2026.
How has the price of MOXIFLOXACIN 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has declined 80.9%. It has been tracked across 430 weekly CMS publications since Jul 11, 2018.
What are the highest and lowest recorded NADAC prices for MOXIFLOXACIN 0.5% EYE DROPS?
Since Jul 11, 2018, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has ranged from a low of $1.5386 (Aug 19, 2026) to a high of $8.3576 (Jul 11, 2018), with a median of $3.6153 per ML.
Are there cheaper alternatives to MOXIFLOXACIN 0.5% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MOXIFLOXACIN 0.5% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures MOXIFLOXACIN 0.5% EYE DROPS?
MOXIFLOXACIN 0.5% EYE DROPS (NDC 65862084003) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.